151751-Najiba-Chargi

71 Diagnostics: measuring skeletal muscle mass of the musculus masseter REFERENCES 1. Chow LQM. Head and Neck Cancer. Longo DL, ed. N Engl J Med . 2020;382(1):60-72. doi:10.1056/NEJMra1715715 2. Leemans CR, Snijders PJF, Brakenhoff RH. The molecular landscape of head and neck cancer. Nat Rev Cancer . 2018;18(5):269-282. doi:10.1038/nrc.2018.11 3. Elicin O, Mahmut Ozsahin E. Head and neck cancer. Med Radiol . 2018:91-126. doi:10.1007/174_2017_32 4. Wong A, Zhu D, Kraus D, Tham T. Radiolog - ically Defined Sarcopenia Affects Survival in Head and Neck Cancer: A Meta-Analy - sis. Laryngoscope . 2020:1-9. doi:10.1002/ lary.28616 5. Cruz-Jentoft AJ, Baeyens JP, Bauer JM, et al. Sarcopenia: European consensus on definition and diagnosis. Age Ageing . 2010;39(4):412-423. doi:10.1093/ageing/ afq034 6. Cruz-Jentoft AJ, Sayer AA. Sarcope - nia. Lancet . 2019;393(10191):2636-2646. doi:10.1016/S0140-6736(19)31138-9 7. Fearon K, Strasser F, Anker SD, et al. Defini - tion and classification of cancer cachexia: An international consensus. Lancet Oncol . 2011;12(5):489-495. doi:10.1016/S1470- 2045(10)70218-7 8. Chasen MR, Bhargava R. A descriptive review of the factors contributing to nutri- tional compromise in patients with head and neck cancer. Support Care Cancer . 2009;17(11):1345-1351. doi:10.1007/s00520- 009-0684-5 9. Almada-Correia I, Neves PM, Mäkitie A, Ravasco P. Body Composition Evalua - tion in Head and Neck Cancer Patients: A Review. Front Oncol . 2019;9. doi:10.3389/ fonc.2019.01112 10. Weerink LBM, van der Hoorn A, van Leeu - wen BL, de Bock GH. Low skeletal muscle mass and postoperative morbidity in sur- gical oncology: a systematic review and meta-analysis. J Cachexia Sarcopenia Muscle . 2020;11(3):636-649. doi:10.1002/ jcsm.12529 11. Wendrich AW, Swartz JE, Bril SI, et al. Low skeletal muscle mass is a predictive factor for chemotherapy dose-limiting toxicity in patients with locally advanced head and neck cancer. Oral Oncol . 2017;71:26-33. doi:10.1016/j.oraloncology.2017.05.012 12. Rier HN, Jager A, Sleijfer S, Maier AB, Levin M. The Prevalence and Prognostic Value of Low Muscle Mass in Cancer Patients: A Review of the Literature. Oncologist . 2016;21(11):1396-1409. doi:10.1634/theon - cologist.2016-0066 13. Ansari E, Chargi N, van Gemert JTM, et al. Low skeletal muscle mass is a strong pre- dictive factor for surgical complications and a prognostic factor in oral cancer patients undergoing mandibular recon- struction with a free fibula flap. Oral Oncol . 2020;101:104530. doi:10.1016/j.oraloncolo - gy.2019.104530 14. Economopoulou P, de Bree R, Kotsantis I, Psyrri A. Diagnostic tumor markers in head and neck squamous cell carcinoma (HNSCC) in the clinical setting. Front Oncol . 2019;9(AUG). doi:10.3389/fonc.2019.00827 15. Shen W, Punyanitya M, Wang ZM, et al. Total body skeletal muscle and adipose tissue volumes: Estimation from a single abdominal cross-sectional image. J Appl Physiol . 2004;97(6):2333-2338. doi:10.1152/ japplphysiol.00744.2004 16. Swartz JE, Pothen AJ, Wegner I, et al. Feasibility of using head and neck CT im - aging to assess skeletal muscle mass in head and neck cancer patients. Oral Oncol . 2016;62:28-33. doi:10.1016/j.oraloncolo - gy.2016.09.006 4